Evidence map›Paper›PMID 42075996›Full record

ArticleMolecules (Basel, Switzerland)2026

Molecular and Pharmacokinetic Rationale for the Use of

Ana Borges, Carlos Seiti H Shiraishi, Rui M V Abreu, María Luisa Martín Calvo, Josiana A Vaz, Ricardo C Calhelha

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana BorgesCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0009-0009-8809-0541
Carlos Seiti H ShiraishiCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0000-0002-4174-8985
Rui M V AbreuCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0000-0002-7745-8015
María Luisa Martín CalvoGrupo de Investigación en Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno s/n, 37007 Salamanca, Spain.ORCID 0000-0003-4810-9673
Josiana A VazResearch Center for Active Living and Wellbeing (LiveWell), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0000-0002-6989-1169
Ricardo C CalhelhaCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0000-0002-6801-4578

Funding

Fundação para a Ciência e Tecnologia 10.54499/CEECINST/00016/2018/CP1505/CT0009Fundação para a Ciência e Tecnologia 10.54499/PTDC/BTA-BTA/0696/2020Fundação para a Ciência e Tecnologia 2023.04950.BDFundação para a Ciência e Tecnologia LA/P/0007/2020Fundação para a Ciência e Tecnologia UID/06157/2025Fundação para a Ciência e Tecnologia UIDB/00690/2020Fundação para a Ciência e Tecnologia UIDP/00690/2020
6 · The paper itself

Abstract

Wound healing involves the coordinated regulation of inflammation, angiogenesis, and extracellular matrix remodeling, processes modulated by natural bioactives. In this context,

Indexed as

Chelidonium majusPlant ExtractsWound HealingAnimalsComputer SimulationFibroblastsHumansMolecular Docking SimulationPlant Extractsbioactive natural compoundsgreater celandinein silico predictionwound healing

Identifiers

PMID42075996
PMCPMC13118405

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.